Progress of circulating tumor DNA in cervical cancer
10.3760/cma.j.cn115355-20221206-00771
- VernacularTitle:血液循环肿瘤DNA在子宫颈癌中的研究进展
- Author:
Zhiwei LI
1
;
Xinjia HE
;
Linqing YANG
;
Jing XU
Author Information
1. 济宁医学院临床医学院，济宁 272000
- Keywords:
Uterine cervical neoplasms;
Circulating tumor DNA;
Diagnosis;
Treatment;
Prognosis
- From:
Cancer Research and Clinic
2023;35(7):552-556
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is a leading cause of cancer death in women. There are no reliable noninvasive indicators to predict the recurrence, metastasis and prognosis of cervical cancer. Circulating tumor DNA (ctDNA) is a kind of DNA fragment released from tumor cells into the blood circulation, which has the advantages of being non-invasive, real-time, and of reflecting the genetic characteristics of tumors. With the improvement of ctDNA detection technology and in-depth research on ctDNA, ctDNA has shown more obvious advantages in early diagnosis, tumor molecular typing, treatment monitoring and recurrence prediction of cervical cancer compared with traditional histological, serological and imaging detection methods. This paper reviews the detection methods of ctDNA and its latest research progress of ctDNA in cervical cancer.
